Christopher J. Donovan is a partner in the law firm of McDermott Will & Emery LLP and is based in the Firm’s Boston office. He focuses his practice on advising companies and their investors and lenders in mergers and acquisitions, recapitalizations, buyouts and restructurings as well as advising on a broad range of commercial arrangements. Christopher has particular expertise in the health service, particularly post-acute, and life sciences sectors. He has a unique blend of deep regulatory as well as corporate and finance expertise to bring to a transaction as a result of his consummating dozens of health and life science deals, both domestic and international.
While in law school, Christopher was a member of the Boston College International Comparative Law Review.
Representative Transactions
- Represented a German multi-national in connection with its acquisition from a major U.S. life science company of its dental antibiotic product and division consisting of a market leading drug, entire workforce and related supply chain
- Represented a German multi-national in connection with the acquisition of technology assets from a U.S. public company, including assets in the United States, Malaysia, Singapore and Switzerland; work included world-wide anti-trust approvals
- Represented a Canadian publicly traded long term care company in its $2.7 billion go-private transaction in the United States
- Represented one of the largest global private equity firms in connection with its acquisition of a healthcare information technology service, including regulatory, fraud and abuse and reimbursement related services in the United States
- Represented several major U.S. based skilled nursing and ancillary service providers in connection with acquisition and debt financing transactions totaling over $5 Billion.
- Represented several private equity companies in the leveraged buyout of a major behavioral health chain.
- Outside U.S. general counsel to one of the premier global management consulting firms including benefits, litigation, bankruptcy, investment, anti-trust, trade and general corporate advice.
- Represent a German-based, global precious metals company and U.S. affiliates in numerous U.S. mergers and acquisition involving precious metal manufacturing concerns including those related to auto OEM products, medical device components and related businesses.
- Represented one of the largest US-based private equity firms in connection with U.S. healthcare regulatory matters transactions.
Recent Speeches
- "U.S. Healthcare Reform and Its Impact on European Business Strategies and Opportunities" – June, 2010, sponsored by the American Chamber of Commerce, Munich, Germany
- "U.S. Healthcare Reform and Its Impact on European Business Strategies and Opportunities" – June, 2010, Berlin, Germany
- "Understanding How Cross-Border M&A Has Been Impacted by the Great Recession in the Credit Crunch" – September, 2010, sponsored by McDermott Will & Emery
- "Medical Product Outsourcing Symposium – Pitfalls and Opportunities of Negotiating Medical Device and Pharmaceutical Outsourcing Agreements" – November, 2010, Waltham, MA
- "BD/Finance: BioPharmaceutical Business in China – Navigating the New Silk Road" – March, 2011, sponsored by MassBio, Cambridge, MA
- "Raising Capital in the U.S. in Today's Market – Opportunities and Strategies for Offshore Companies" – May, 2011, sponsored by Medicon Valley Alliance and McDermott Will & Emery
- "International Precious Metals Institute Conference – Conflict Gold: Big, Bad and Ugly" – June, 2011, San Antonio, Texas
- AdvaMed 2011 – The Med Tech Conference – "Negotiating Medical Product Outsourcing Agreements: Pitfalls and Strategies" – September, 2011 – Washington, D.C.
- Webcast: Life Sciences: Understanding Opportunities and Challenges for Improved Business Results - Integrated Due Diligence for Life Sciences Companies; Enhancing and Preserving Valuation – November, 2011; sponsored by McDermott Will & Emery
Other Activities:
- Chris has been a cyclist as well as fundraiser for the Pan Massachusetts Challenge for the last eight years. The PMC is an annual charity bikeathon that has raised millions of dollars for cancer research and is the largest single donor to the Dana Farber Cancer Hospital in Boston.
Education
- Boston College Law School, J.D., 1981
- Georgetown University, B.S.F.S. (magna cum laude), 1978
